Outstanding among his contributions is the discovery and development of Desmoteplase, a fibrinolytic agent originally extracted from the saliva of vampire bats, useful in the treatment of thromboembolic disorders, contributing to a reduction of neuronal damage in cerebrovascular diseases.

He has developed, also with original research, antivenins for poisonous animals with a purity and refinement that significantly reduce the adverse reactions that are typical of these emergency therapies. His technological innovation model is recognized as a successful case of academic linkage. 

He is a former head of the Departamento de Medicina Molecular y Bioprocesos [Molecular Medicine and Bioprocesses Department] and Academic Secretary of the Centro de Investigaciones sobre Ingeniería Genética [Genetic Engineering Research Center], today, Instituto de Biotecnología de la UNAM [UNAM’s Institute of Biotechnology]. He has coordinated masters and doctoral programs on Biochemical Sciences and Basic Biomedical Research at the UNAM. 

He was awarded the Premio Universidad Nacional [National University Prize] for Technological Innovation and Industrial Design. He was elected to chair the Pan-American section of the International Society on Toxinology, and was granted the Premio Nacional de Ciencias y Artes [National Award for Science and Arts]. 

He has published 86 scientific articles, with 585 citations, and has tutored more than 25 B.S., M.S. and PhD theses. He has been awarded 7 patents related to antivenins and antiplatelet aggregation.